Get the Stockscreener App
0.00
2.94%
-0.102
Neximmune Inc stock is traded at $0.00, with a volume of 0.
It is down -2.94% in the last 24 hours and down -22.22% over the past month.
See More
Previous Close:
$0.102
Open:
$0
24h Volume:
0
Relative Volume:
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-20.62M
P/E Ratio:
0.00
EPS:
-18.54
Net Cash Flow:
$-17.61M
1W Performance:
-2.94%
1M Performance:
-22.22%
6M Performance:
-74.07%
1Y Performance:
+623.57%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.00
Neximmune Inc Stock (NEXI) Company Profile
Compare NEXI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEXI
Neximmune Inc
|
0.00 | 0 | 0 | -20.62M | -17.61M | -18.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 116.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.94 | 82.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.25 | 52.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.90 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.09 | 37.61B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neximmune Inc Stock (NEXI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-21 | Initiated | Raymond James | Outperform |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-09-21 | Initiated | Cantor Fitzgerald | Overweight |
Neximmune Inc Stock (NEXI) Latest News
NexImmune (NASDAQ:NEXI) Stock Price Up 2,169,900% – Here’s Why - Defense World
NexImmune (NASDAQ:NEXI) versus Avenue Therapeutics (NASDAQ:ATXI) Head-To-Head Comparison - Defense World
Aktis Oncology files for US IPO as biotech listings rebound - marketscreener.com
Nasdaq Inc will be open as scheduled on Wednesday, December 24, 2025, and Friday, December 26, 2025 - marketscreener.com
Intellego board has asked Nasdaq to keep trading halted - marketscreener.com
Tradeweb CEO says round-the-clock trading to become mainstream - marketscreener.com
Alerts, brief on Cybin transferring US listing to Nasdaq withdrawn - marketscreener.com
Nasdaq sees bigger year ahead for listings on billion-dollar-plus IPOs - marketscreener.com
Ben strengthens balance sheet with over $1.24 million in liability reductions - marketscreener.com
Blank Check Co, Proem Acquisition Corp I files for IPO of up to $130 million - marketscreener.com
RTW Biotech invests USD5.9 million in Yarrow Bioscience funding round - marketscreener.com
Launchpad Cadenza Acquisition Corp I Prices IPO - marketscreener.com
SS Lazio, a global brand between the stock market and US ambitions - marketscreener.com
Nasdaq seeks to extend trading hours to nearly round-the-clock - marketscreener.com
Bitcoin hoarding company Strategy remains in Nasdaq 100 - marketscreener.com
Nasdaq submits new plan with more power to block IPOs vulnerable to manipulation - marketscreener.com
Nasdaq seeks more power to block IPOs vulnerable to manipulation - marketscreener.com
Critical Survey: NexImmune (NASDAQ:NEXI) and Palatin Technologies (PINK:PTNT) - Defense World
Critical Review: NexImmune (NASDAQ:NEXI) and Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World
NexImmune (NASDAQ:NEXI) versus iBio (NYSE:IBIO) Financial Survey - Defense World
Head-To-Head Survey: NexImmune (NASDAQ:NEXI) versus Evotec (OTCMKTS:EVTCY) - Defense World
Central Bancompany valued at $5.26 billion in Nasdaq debut - marketscreener.com
Wall Street opens higher as Nvidia test looms - marketscreener.com
Sampo Gets Berenberg’s Vote As Nordic Insurance Leader - Finimize
Total debt per share of NexImmune, Inc. – LS:A3EUTV - TradingView
Evolution Global Acquisition Shares Rise in Nasdaq Debut - marketscreener.com
Nasdaq Scores Best Day Since May on Optimism Over Shutdown Resolution - marketscreener.com
EU Antitrust Watchdog Probes Deutsche Boerse, Nasdaq Over Financial Derivatives -- Update - marketscreener.com
BlackRock-backed TXSE Group adds US banking giant J.P. Morgan as investor - marketscreener.com
Gloo, with former Intel CEO Gelsinger as tech head, seeks nearly $900 million valuation in IPO - marketscreener.com
Clean Energy Technologies, Inc. regains compliance with Nasdaq listing requirements - marketscreener.com
Qt Imaging Holdings IncSubmits application to relist on Nasdaq - marketscreener.com
NexImmune, Inc. (NEXI) stock price, news, quote and history - Yahoo
Functional Brands expects common stock to begin trading on Nasdaq on or about November 4 - marketscreener.com
Book value per share of NexImmune, Inc. – LS:A3EUTV - TradingView
Light & Wonder announces update on Nasdaq delisting timetable - marketscreener.com
Datavault AI Regains Compliance With Nasdaq Listing Rule - marketscreener.com
Wall Street indexes fall as data raises uncertainty for rate-cut outlook - MarketScreener
Nasdaq & AWS to advance capital markets and banking infrastructure across the financial system - MarketScreener
Tech Values, Fed Outlook Cramp Wall Street Pre-Bell; Asia Mixed, Europe Off - MarketScreener
Rick Perry's data center REIT Fermi targets $13 billion valuation in US IPO - MarketScreener
Wall Street indexes end lower as investors digest Powell comments - MarketScreener
Blank check company, Lafayette Digital Acquisition Corp Ifiles for IPO of up to $250 millionSEC filing - MarketScreener
Thunderstone Acquisition Corp intend to apply units on Nasdaq - MarketScreener
Galata Acquisition Corp. II Closes $172.5 Million IPO - MarketScreener
Voltage X intends to list shares on Nasdaq as 'VXAI' - MarketScreener
Creative Future Acquisition Corp files for IPO of up to $60 mln - MarketScreener
Wall St closes higher with indexes notching weekly gains - MarketScreener
Blank check company Spacsphere Acquisition Corp files for IPOSEC filing - MarketScreener
Ultragenyx reports inducement grant under Nasdaq - MarketScreener
Su group receives notice of delisting from Nasdaq - MarketScreener
Neximmune Inc Stock (NEXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.08%
Cap:
|
Volume (24h):